Table 1.
Clinical characteristics of the individuals that participated in the study.
| Variable | Treatment-naive T2D patients | Well-controlled T2D patients | Healthy individuals |
|---|---|---|---|
| Number (n) | 6 | 6 | 6 |
| Sex | 3M/3F | 4M/2F | 3M/3F |
| Age (years, mean ± SD) | 55.2 ± 9.1 | 56.5 ± 9.8 | 52.5 ± 8.6 |
| FPG (mg/dl, mean ± SD) | 219.3 ± 36.2 | 121.2 ± 20.1 | 90.5 ± 10.9 |
| HbA1c (%, mean ± SD) | 8.7 ± 1.2 | 6.3 ± 0.4 | 5.3 ± 0.3 |
| BMI (kg/m2, mean ± SD) | 31.6 ± 3.9 | 32.9 ± 3.6 | 28.1 ± 3.2 |
| Smoking (n) | 3 | 2 | 2 |
| Hypertension (n) | 5 | 6 | 0 |
| Dyslipidemia (n) | 4 | 3 | 0 |
| CAD (n) | 2 | 2 | 0 |
| CKD (n) | 1 | 2 | 0 |
M, male; F, female; SD, standard deviation; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease.